Cited by 31Glycosylation and Glycoproteins ResearchCarbohydrate Chemistry and SynthesisProteoglycans and glycosaminoglycans research

Glycopeptide N-acetylgalactosaminyltransferase specificities for O-glycosylated sites on MUC5AC mucin motif peptides

Open access
TETAERT, Daniel, TEN HAGEN, Kelly G., RICHET, Colette, BOERSMA, Arnold, GAGNON, Jean, DEGAND, Pierre·2001·Biochemical Journal

Abstract

The recombinant proteins of the two novel UDP-N-acetylgalactosamine (GalNAc) glycopeptide:N-acetylgalactosaminyltransferases (designated gpGaNTase-T7 and gpGaNTase-T9) were assayed with O-glycosylated products obtained from the prior action of the ubiquitous transferases (GaNTase-T1 and GaNTase-T2) towards MUC5AC mucin motif peptides (GTTPSPVPTTSTTSAP and peptides with single amino acid substitutions, GTTPSAVPTTSTTSVP and GTTPSPVPTTSITSVP, that are a reflection of mucin molecule polymorphism). gpGaNTase-T9 is known to be expressed differentially and more abundantly than gpGaNTase-T7 in some tissues; the results of in vitro glycosylation also indicates a difference in acceptor substrate specificities between the gpGaNTase isoforms. With the use of capillary electrophoresis, MS and Edman degradation, our study suggests that, in the O-glycosylation of mucin-type proteins, approach and recognition signalling by gpGaNTase-T7 and gpGaNTase-T9 depend largely on the peptide's primary structure (for example the presence of multiple clusters of hydroxy amino acids and the number of GalNAc residues attached to the peptide backbone). O-glycosylation in terms of sites of attachment seems to be less random than previously described and, if sequential reactions are ordered throughout the Golgi stack, the complete O-glycosylation of the mucin molecules seems to be finely tuned to respond to specific damage to, or attack on, epithelia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj3570313

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previous in vitro studies with GalNAc-T2 have identified Thr9 in the MUC5AC peptide as a preferred glycosylation site.

    “Previous in vitro studies with GalNAc-T2 have identified Thr7 in the synthetic EA2 peptide sequence [14, 15] and Thr9 in the MUC5AC peptide as preferred glycosylation sites [31].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
TETAERT, D., TEN HAGEN, K. G., RICHET, C., BOERSMA, A., GAGNON, J., & DEGAND, P.
Affiliations
  • Unité INSERM No. 377, Biologie et Physiopathologie de Cellules Mucipares, Place de Verdun, 59045 Lille Cédex, France
  • Center for Oral Biology, Aab Institute for Biomedical Sciences, University of Rochester, 601 Elmwood Avenue, Box 611, Rochester, NY 14642, U.S.A.
  • Inserm (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
  • RICHET, Colette
  • BOERSMA, Arnold
  • DEGAND, Pierre
Venue
Biochemical Journal
Published
2001-06-25
Volume
357
Issue
1
Pages
313-320
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2023618350
Cited by
31
References
28
Citations by year
2026: 1 · 2024: 1 · 2022: 1 · 2018: 1 · 2017: 1 · 2015: 1 · 2012: 1
FWCI
1.40
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Keywords
N-acetylgalactosaminyltransferase, O-glycosylation, MUC5AC mucin, acceptor substrate specificity, Golgi glycosylation
MeSH terms
Amino Acid Sequence, Animals, Chlorocebus aethiops, Glycosylation, Isoenzymes, Kinetics, Molecular Sequence Data, Mucins, Peptide Fragments, Peptides, Recombinant Proteins, Substrate Specificity, Transfection, N-Acetylgalactosaminyltransferases, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, COS Cells, Mucin 5AC

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review